Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Effect of Albendazole Dose on Clearance of Filarial Worms [Phase 2]

View source ↗

Summary

This Phase 2 study investigated how different doses of albendazole affect clearance of filarial worms in lymphatic filariasis due to Wuchereria bancrofti; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lymphatic Filariasis, Wuchereria Bancrofti Infection | Phase 2 | Status: COMPLETED